𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Apoptosis of human neutrophils induced by protein phosphatase 1/2A inhibition is caspase-independent and serine protease-dependent

✍ Scribed by Hae-Young Park; Min-Gyu Song; Jun-Sik Lee; Ja-Woong Kim; Jun-O Jin; Joo-In Park; Young-Chae Chang; Jong-Young Kwak


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
639 KB
Volume
212
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Protein phosphatase (PP) activity is associated with the regulation of apoptosis in neutrophils. However, the underlying regulatory mechanism(s) in apoptosis remain unclear. The type of cell death induced by okadaic acid (OA), the inhibitor of PP1 and PP2A, is characterized by apoptotic morphological changes of the cells and annexin V‐positive staining without DNA fragmentation. The apoptotic effects of OA and calyculin A on neutrophils were observed at concentrations ranging from 50 to 200 nM, or 10 to 50 nM, respectively. Cyclosporine A (a PP2B specific inhibitor), however, did not exhibit any pro‐apoptotic effects. OA and calyculin A, but not cyclosporine A, exhibited significant effects on protein levels and on the electrophoretic mobility of Mcl‐1. zVAD‐fmk, a pancaspase inhibitor, failed to inhibit the effect of OA on the caspase‐3 activity, procaspase‐3 processing, and the apoptotic rate of neutrophils. However, 4‐(2‐aminoethyl) benzenesulfonylfluoride (AEBSF), a general serine protease inhibitor, significantly abrogated the OA‐induced mobility shift in procaspase‐3, caspase‐3 activation, and the apoptotic morphological changes in neutrophils. Moreover, OA enhanced the serine protease activity of the neutrophils. The addition of the proteinase‐3 protein increased the rate of neutrophil apoptosis, which was also blocked by AEBSF but not by zVAD‐fmk. These results suggest that OA induces procaspase‐3 processing but that OA‐induced apoptosis is caspase‐independent and serine protease‐dependent. J. Cell. Physiol. 212: 450–462, 2007. © 2007 Wiley‐Liss, Inc.